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Abstract
Background: Staphylococcus aureus [methicillin-resistant and methicillin-susceptible (MRSA/MSSA)] is a leading
cause of infections in military personnel, but there are limited data regarding baseline colonization of
individuals while deployed. We conducted a pilot study to screen non-deployed and deployed healthy military
service members for MRSA/MSSA colonization at various anatomic sites and assessed isolates for molecular
differences.
Methods: Colonization point-prevalence of 101 military personnel in the US and 100 in Afghanistan was
determined by swabbing 7 anatomic sites. US-based individuals had received no antibiotics within 30 days, and
Afghanistan-deployed personnel were taking doxycycline for malaria prophylaxis. Isolates underwent
identification and testing for antimicrobial resistance, virulence factors, and pulsed-field type (PFT).
Results: 4 individuals in the US (4 isolates- 3 oropharynx, 1 perirectal) and 4 in Afghanistan (6 isolates- 2
oropharynx, 2 nare, 1 hand, 1 foot) were colonized with MRSA. Among US-based personnel, 3 had USA300
(1 PVL+) and 1 USA700. Among Afghanistan-based personnel, 1 had USA300 (PVL+), 1 USA800 and 2 USA1000.
MSSA was present in 40 (71 isolates-25 oropharynx, 15 nare) of the US-based and 32 (65 isolates- 16
oropharynx, 24 nare) of the Afghanistan-based individuals. 56 (79%) US and 41(63%) Afghanistan-based
individuals had MSSA isolates recovered from extra-nare sites. The most common MSSA PFTs were USA200
(9 isolates) in the US and USA800 (7 isolates) in Afghanistan. MRSA/MSSA isolates were susceptible to
doxycycline in all but 3 personnel (1 US, 2 Afghanistan; all were MSSA isolates that carried tetM).
Conclusion: MRSA and MSSA colonization of military personnel was not associated with deployment status or
doxycycline exposure. Higher S. aureus oropharynx colonization rates were observed and may warrant changes
in decolonization practices.
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Background
The US military has continually dealt with the challenges
of controlling and treating Staphylococcus aureus infec-
tions, as was evident by the development of penicillin-
resistant strains soon after penicillin’s introduction into
battlefield medicine during World War II [1]. Increasing
antimicrobial resistance remained a challenge during the
Vietnam War and has continued to present-day in the
wars in Iraq and Afghanistan [2-8]. In addition to the chal-
lenges with S. aureus in the war zone, methicillin-resistant
S. aureus (MRSA) and methicillin-susceptible S. aureus
(MSSA) have caused substantial skin and soft tissue infec-
tions among military personnel not deployed to a combat
zone [9-11]. To mitigate excess morbidity and mortality
from MRSA and MSSA, studies have attempted to better
define pathogen epidemiology, identify associated risk fac-
tors for both colonization and infection; and implement
decolonization strategies [12-14]. However, several studies
suggest continuing epidemiological shifts in antimicrobial
resistance profiles, sites of colonization, and infection rates
of MRSA and MSSA [9,15-20].
Given the ongoing healthcare challenges of MRSA and
MSSA in military personnel in austere environments, a
better understanding of microbial epidemiology dynamics
in the context of deployment is necessary to facilitate ef-
fective disease control strategies. Combat deployments, as
well as humanitarian and disaster relief missions, often
occur in environments not conducive to adequate hygiene
practices. Further, these deployments are often to geo-
graphic regions that require antimalarial chemoprophy-
laxis. The use of doxycycline for malaria prevention has
raised concerns about potential inducible resistance and
its impact on MRSA treatment and decolonization [21].
Therefore, we conducted a pilot study of two populations
of military personnel (one in the US and one in
Afghanistan) to determine MRSA and MSSA colonization
prevalence and evaluate different anatomic sites, pulsed-
field types (PFTs), antimicrobial resistance, and S. aureus
virulence and resistance genes.
Methods
Participants
Two populations of healthy active duty service members
(101 non-deployed personnel in San Antonio, Texas,
USA and 100 personnel deployed to Afghanistan) were
assessed in this study. Recruitment of participants oc-
curred in an outpatient medical clinic, at the time of
presentation for acute, non-urgent care. All participants
were 18 years or older. Exclusion criteria for the non-
deployed participants were: overseas travel or deploy-
ment within 6 months, antibiotic use within 30 days,
and an active infection that may have altered a study
participant’s normal flora or involved a proposed ana-
tomic sample site. The deployed personnel resided in a
single province in Afghanistan for approximately 7 months.
These were healthy individuals without active infections,
who were taking doxycycline for malaria chemoprophy-
laxis (100 mg orally daily). Demographic characteristics
were obtained using a short questionnaire. Brooke Army
Medical Center and the US Army Medical Research and
Material Command Institutional Review Boards approved
the two studies and consent forms.
Surveillance cultures
Troop medical clinic, San Antonio, TX
Cultures were collected from seven anatomical sites
(nare, oropharynx, axilla, groin, web spaces of domin-
ant hand, web spaces of the foot, and perirectal area)
using pre-moistened swabs (Copan, Stuart liquid media
culture, Copan Inc., Brescia, Italy) over a 2 month
time period (May-June, 2011). Swabs were immediately
transported to the laboratory and plated onto Trypticase
Soy Agar with 5% sheep blood (sheep blood agar), as well
as CHROMagar™ S. aureus plates for rapid detection of
S. aureus. After incubation at 35°C, colonies with morph-
ology consistent with S. aureus on sheep blood agar and
mauve colored large colonies from CHROMagar™ S. aur-
eus media were subcultured onto sheep blood agar in
order to ensure culture purity. All isolates were frozen at
−80°C in Trypticase Soy Broth (TSB) with 15% glycerol.
Acute care clinic in Afghanistan
Samples were collected from deployed participants in
Afghanistan using BD CultureSwabTM Max V(+) (Becton
Dickinson, Franklin Lakes, NJ), which contain Amies
medium and a unique blend of non-animal proteins em-
bedded into the swab fibers, providing additional nutri-
ents for survival of microorganisms during transport.
Collection of samples occurred over a one month time
period (August, 2011) using the same method described
for the US study site. The isolates were stored at room
temperature, as this was previously shown to be the op-
timal storage temperature for preservation and stability
of collected bacteria for up to 4 weeks. The swabs were
sent to San Antonio Military Medical Center in two sep-
arate shipments (14 days apart) for pathogen recovery as
described above.
Antimicrobial susceptibility testing
Frozen isolates underwent automated testing for identifi-
cation and susceptibilities with the BD Phoenix Auto-
mated Microbiology System (Becton Dickinson and
Company, Franklin Lakes, NJ), using the PMIC/ID-107
panels per manufacturer’s instructions. Confirmation for
doxycycline susceptibility of all S. aureus isolates was
done using the PMIC/ID-106 panels. MRSA was defined
as S. aureus with evidence of oxacillin or cefoxitin resist-
ance and detection of the mecA gene. MSSA was defined
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as S. aureus without resistance to oxacillin or cefoxitin
and no detection of the mecA gene.
Molecular testing
Frozen isolates of S. aureus underwent pulsed-field gel elec-
trophoresis (PFGE) as described elsewhere [22]. PFGE gels
were analyzed using the commercial software BioNumerics
(Applied Maths Inc., Austin, TX) and clonality was assessed
using established criteria [22,23]. Isolates were screened
for the presence of antimicrobial resistance genes coding
for resistance to various antimicrobial agents including
β-lactam antibiotics (SCCmec), methicillin-oxacillin (mecA),
macrolide-lincosamide-streptogramin (ermA, ermB, ermC,
ermT), macrolide (msrA), penicillin (blaZ), tetracyclines
(tetK, tetL, tetM, tetO), trimethoprim (dfrA, dfrK),
aminoglycosides (aac(6′)-aph(2′)), quaternary ammonium
compounds (smr, qacA/B), and mupirocin (mupA). Using
PCR, isolates were also screened for the presence of viru-
lence factors (Panton-Valentine leukocidin - PVL, Arginine
Catabolic Mobile Element - ACME) and accessory gene reg-
ulators (Agr) associated with pathogenicity of the organisms.
For PCR testing, genomic DNA was extracted from
overnight cultures using the QIAamp DNA Mini Kit
(Qiagen, Valencia, CA) following the manufacturer’s
protocol. All PCRs were conducted with Eppendorf Mas-
ter Mix (Eppendorf, Hamburg, Germany) containing 1.25
U Taq DNA polymerase, 1.5 mM Mg2+ and 200 μM of
each dNTP final concentrations in the PCR and with a
final volume of 25 μl. The PVL gene was detected using
400 nM of primers luk-PV-1, 5′-ATCATTAGGTAAA TG
TCTGGACATGATCCA-3′, and luk-PV-2, 5′-GCATCAA
CTGTATTGGATAGCAA AAGC-3′ amplifying a 433 bp
PVL product and the following PCR conditions: 94°C for
2 min followed by 30 cycles of 30 s at 94°C, 30 s at 55°C
and 1 min at 72°C followed by a final extension 5 min at
72°C. S. aureus ATCC 49775 was used as positive amplifi-
cation controls. The isolates were screened for the pres-
ence of the arcA gene by PCR using the primer pair arcA-
F 5′-GAGCCAGAAGTACGCGAG-3′ and arcA-R 5′-CA
CGTAACTTGCT AGAACGAG-3′. The arcA gene be-
longs to the arc gene cluster which is a surrogate marker
for type I ACME. Amplification was carried out for 30 cy-
cles with denaturation at 94°C for 20 s, annealing at 55°C
for 30 s, extension at 72°C for 30 s, and a final extension
at 72°C for 5 min using 400 nM concentrations of the
primers resulting in an amplification product of 724 bp. S.
epidermidis ATCC 12228 was used as positive control for
all PCR runs. All PCR products were resolved by electro-
phoresis through 1.2% or 2% agarose gels and visualized
with ethidium bromide.
Statistical analysis
All statistical analyses, to include descriptive statistics
and categorical variable comparisons using Pearson χ-
square or Fisher’s Exact Test, were performed using
SPSS (IBM®SPSS®Statistics Version 19). All p values were
two-tailed and a value of <0.05 was considered statisti-
cally significant.
Results
Troop medical clinic, San Antonio, TX
Of 101 participants, two refused collection at the
perirectal site and one refused collection at the oropha-
ryngeal site, resulting in a total of 704 collected swabs.
Median age was 23 years (IQR 22, 23), with a male pre-
dominance (69%). Most (85%) of the individuals had
been born in the United States and 81% were in the
Army. Study participants had been on active duty mili-
tary service for a mean time of 9 months and assigned
to their current base for a mean period of 3 months.
Acute care clinic, Afghanistan
Collection of samples from 100 healthy participants
deployed to Afghanistan yielded 700 samples. Median
age was 24 years (IQR 24, 25) and all study participants
were male. All personnel were in the Army and 84% of
them performed foot patrols outside of the base, possibly
predisposing them to more local population and envir-
onmental exposures.
Comparison of Staphylococcus aureus colonization in US
and Afghanistan personnel
MRSA
There were 4 personnel colonized with MRSA in each
study population (Table 1). All MRSA colonized personnel
in Afghanistan participated in operations outside of the
base. In the US population, MRSA was isolated from oro-
pharynx and perirectal sites while the Afghanistan MRSA
isolates were identified from oropharynx, nares, hand and
foot swabs (Table 1). All MRSA isolates in the US
personnel were isolated from a single site on each subject,
while 2 Afghanistan-based personnel had co-colonization
with the same strain of MRSA at different anatomical sites
(one with nares and oropharynx and the other with hand
and foot co-colonization). Of the US-based personnel, 3
(75%) participants were colonized with community-
associated USA300 MRSA, and 1 (25%) with healthcare-
associated USA700 MRSA. Comparison of USA300 and
USA400 MRSA in the US and Afghanistan personnel re-
vealed statistical significance of increased prevalence of
USA300 isolates in the US personnel compared to the
Afghanistan personnel (p < 0.01).
All MRSA isolates, from both populations, were sus-
ceptible to doxycycline, minocycline, tetracycline, rifam-
pin, and trimethoprim-sulfamethoxazole in addition to
vancomycin and daptomycin. Half of the MRSA isolates
in the US personnel and 100% of MRSA isolates in the
Afghanistan personnel demonstrated fluoroquinolone
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Table 1 Differences in methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA)
colonization in 101 healthy US military personnel in the US and 100 US military personnel deployed to Afghanistan
MRSA MSSA
Demographics US Afghan Total US Afghan T otal
Number of personnel (isolates) 4 (4) 4 (6) 8 (10) 40 (71) 32 (65) 72 (136)
Age median (IQR) 24 (24,25) 23 (22,23) 23 (23,24) 21 (20,25) 23 (22,26) 22 (21,25)
Gender – males% 50 100 75 69 100 84
Operations off the military basea 4 4 25 25
Location of isolate colonization
Nares 2 2 15 24 39
Oropharynx 3 2 5 25 16 41
Axilla 0 4 4 8
Groin 0 7 6 13
Hand 1 1 4 6 10
Foot 1 1 8 9 17
Perirectal 1 1 8 8
Number of sites colonized by subjectb
1 4 2 6 21 15 36
2 2 2 9 8 17
3 0 7 4 11
4 0 3 3 6
5 0 0 2 2
Personnel co-colonized at multiple sites
Nares and oropharynx 1 1 2 6 8
Nares and hand 1 1
Nares and axilla 1 1
Nares and groin 2 1 3
Nares and perirectal 1 1
Hand and foot 1 1
Oropharynx and perirectal 1 1
Oropharynx and foot 1 1
Groin and hand 1 1
Nares, oropharynx and groin 1 1 2
Nares, oropharynx and perirectal 1 1 2
Nares, axilla and perirectal 1 1
Nares, groin and foot 1 1 2
Nares, oropharynx and foot 1 1 2
Nares, oropharynx and hand 1 1 2
Axilla, groin, foot and perirectal 1 1
Nares, oropharynx, axilla and foot 1 1
Nares, oropharynx, groin and foot 1 1
Nares, hand, groin and foot 1 1
Nares, oropharynx, axilla and hand 1 1
Nares, oropharynx, hand and foot 1 1
Nares, oropharynx, axilla, hand and foot 1 1
Nares, oropharynx, axilla, groin and foot 1 1
aOnly Afghanistan personnel eligible.
bp-value <0.01 – Comparing MSSA and MRSA sites of colonization in all study personnel.
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susceptibility. Clindamycin resistance was noted in 25%
of isolates, with the ermC gene found in 25% of MRSA
isolates in US personnel. 25% of the US MRSA isolates
appeared to have inducible clindamycin resistance, based
on automated testing results for inducible MLSb pheno-
type. Additional resistance genes tested, including aac
(6′)-aph(2′) for aminoglycoside resistance, smr, qacA/B,
and mup, were not found in any MRSA isolates.
Only 25% of all MRSA isolates in Afghanistan and US
personnel possessed PVL, and 50% of US and 25% of
Afghanistan MRSA isolates were positive for ACME.
Agr I was found in 100% of US and 25% of Afghanistan
isolates, and Agr II was found in 25% of Afghanistan iso-
lates (Table 2).
MSSA
A total of 136 MSSA isolates were found to colonize 72
individuals: 40 personnel stationed in the US and 32
deployed to Afghanistan (Table 1). The most commonly
colonized site was the oropharynx (62%) in the US
personnel and nares (50%) in the Afghanistan personnel,
and most of the participants were colonized at a single
anatomical site (Table 1). Two US-based individuals
were co-colonized with MRSA and MSSA at different
sites, while no Afghanistan-based individuals were colo-
nized with both MSSA and MRSA. A total of 77 unique
(by genotype and individual study participant) MSSA
isolates (42 in the US and 35 in the Afghanistan
personnel) were identified and are represented under the
CA- and HA-MRSA sections in Table 2. Only 10% of
the US and 9% of the Afghanistan MSSA isolates were
found to be USA300 and USA400 types (most com-
monly associated with community-associated strains),
while the remainder were other USA and non-USA
strain-types (Table 2). The most common MSSA PFTs
were USA200 (9 isolates) in the US and USA800 (7 iso-
lates) in Afghanistan.
All isolates were susceptible to ampicillin-sulbactam
and rifampin. Clindamycin susceptible isolates were
found in 83% of personnel in each study group, with evi-
dence of the presence of the ermA gene in 17% of the
US and 11% of the Afghanistan personnel. Fluoroquino-
lone resistance (2%) was only seen in the US study
group. Minocycline susceptibility (98% of total isolates,
100% in US study group) was greater than tetracycline
susceptibility (87% of total MSSA isolates), and the tetK
and tetM genes were identified in isolates from the
Afghanistan study personnel (Table 2). 98% of US-based
and 94% of Afghanistan-based isolates were doxycycline
susceptible. Trimethoprim-sulfamethoxazole resistance
of 4% was seen only in the US personnel.
Additional resistance genes tested were aac(6′)-aph
(2′) for aminoglycoside resistance (0% in US and 48%
Afghanistan isolates), smr (2% US isolates), and qacA/B,
mupA (not found in any MSSA isolates). Only 2% of all
MSSA isolates carried PVL, while none carried ACME.
Agr I and Agr II were present in approximately one
third of MSSA isolates (Table 2).
Comparison of MRSA and MSSA isolates
PFT USA300 was common among MRSA isolates
(75%) for the US-based personnel (Table 2). Ampicillin-
sulbactam, erythromycin, and fluoroquinolone (levofloxacin
and moxifloxacin) susceptibility was significantly more
prevalent among MSSA isolates (Table 2). There were no
differences in doxycycline, minocycline or tetracycline sus-
ceptibility between MRSA or MSSA isolates recovered in
the US or Afghanistan. Significantly more MRSA isolates
were associated with virulence factors such as PVL and
ACME and the erythromycin resistance gene, msrA,
whereas more MSSA isolates were associated with tetracyc-
line resistance genes (tetK, tetM) (Table 2).
Discussion
Continual surveillance for MRSA and MSSA colonization
is required to ensure appropriate care is being pro-
vided, especially when people are located in austere
environments, such as war or natural disasters, and
exposed to antimicrobial pressure, such as antimalarial
chemoprophylaxis. Earlier studies of healthy military
personnel, carried out at the same US base, revealed
MRSA and MSSA colonization rates of 1.5-4% and
20-38%, respectively; however, these studies only
screened the nares [10,12]. In our study, six out of
8 MRSA colonized personnel would not have been
detected if nare-only surveillance was performed and
among MSSA isolates, colonization of the oropharynx
was higher among personnel in the US than in
Afghanistan. A study of VA patients in Boston indi-
cated that only 2% of personnel had extra-nare only
colonization; however, these patients did not have typical
community-associated MRSA risk factors [18]. An urban
emergency department (ED) study revealed 39% MSSA
(156 of 400 personnel) and 5% MRSA (20 of 400
personnel) colonization [17]; 80% of personnel with
MRSA were extra-nare and 45% were only extra-nare,
with the oropharynx being the most commonly colonized
site. A cross-sectional study of adults and children with S.
aureus skin infections and their household contacts indi-
cated that a nare-only survey would have missed 38% of
MSSA and 51% of MRSA colonized persons [20]. Overall,
most studies focus on patient populations with a history
of ongoing skin infection or substantial risk factors of
MRSA colonization; however, the literature increasingly
supports the role of extra-nare site screening, especially
the oropharynx [24-26].
As shown in previous studies of US military personnel,
USA300 was a commonly recovered MRSA strain,
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Table 2 Pulsed-field types, antimicrobial resistance, and resistance and virulence genes, of methicillin-resistant S.
aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates from personnel screened in the US and
Afghanistan
MRSA MSSA
US Afghan Total US Afghan Total
Pulsed-field types a 4 4 8 42 35 77
Community-associated isolates n(%) 3(75) 1(25) 4(50) 4(10) 3(9) 7 (9)
USA 300 3(75)c 1(25) 4(50)d 2(5)c 2(6) 4(5)d
USA 400 0 0 0 2(5) 1(3) 3(4)
Healthcare-associated isolates n(%) 1(25) 3(75) 4(50) 38(90) 32(91) 70(91)
USA 200 0 0 0 9(21) 6(17) 15(20)
USA 500 0 0 0 0 5(14) 5(6)
USA 600 0 0 0 2(5) 1(3) 3(4)
USA 700 1(25) 0 1(12) 0 2(6) 2(3)
USA 800 0 1(25) 1(12) 7(16) 7(20) 14(18)
USA 900 0 0 0 5(12) 2(6) 7(9)
USA 1000 0 2(50) 2(12) 2(5) 5(14) 7(9)
Other (%) 0 0 0 13(31) 4(11) 17(22)
Antimicrobial susceptibility and presence of antimicrobial resistance gene n(%)b 4 4 8 47 35 82
Ampicillin 0 0 0 0 0 0
Ampicillin-sulbactam 0 0 0e 47(100) 35(100) 82(100)e
Penicillin G 0 0 0 10(21) 6(17) 16(19)
blaZ 4(100) 4(100) 8(100) 36(77) 29(83) 65(79)
Clindamycin 3(75) 4(100) 7 (87) 39(83) 29(83) 68(83)
ermA 0 0 0 8(17) 4(11) 12(15)
ermB and ermT 0 0 0 0 0 0
ermC 1(25) 0(0) 1 (12) 0 0 0
Erythromycin 0 1(25) 1 (12)f 34(72) 22(63) 56(68)f
msrA 3(75)g 3(75) 6(75)h 2(4)g 8(23) 10(12)h
ermA 1(25) 0 1(12) 8(17) 4(11) 12(15)
Levofloxacin 2(50)i 4(100) 6(75)j 46(98)i 35(100) 81(99)j
Moxifloxacin 2(50)k 4(100) 6(75)l 46(98)k 35(100) 81(99)l
Rifampin 4(100) 4(100) 8(100) 47(100) 35(100) 82(100)
Doxycycline 4(100) 4(100) 8(100) 46(98) 33(94) 79 (98)
Minocycline 4(100) 4(100) 8(100) 47(100) 33(94) 80(98)
Tetracycline 4(100) 4(100) 8(100) 46(98) 25(71) 71(87)
tetK 0 0 0 0m 6(17)m 6(7)
tetL and tetO 0 0 0 0 0 0
tetM 0 0 0 1(2)n 2(6)n 3(4)
Trimethoprim - sulfamethoxazole 4(100) 4(100) 8(100) 45(96) 35(100) 80(98)
dfrA and dfrK 0 0 0 0 0 0
Other resistance and virulence markers (%)b 4 4 8 47 35 82
mecA 4(100) 4(100) 8(100) 0 0 0
SCCmec 4(100) 4(100) 8(100) 0 0 0
PVL 1(25) 1(25) 2(25)o 1(2) 1(3) 2(2)o
ACME 2(50)p 1(25) 3(37)q 0p 0 0q
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accounting for only 55% of colonizing nare isolates, which
is the same percentage as the urban ED colonization study
[10,12,17]. The family transmission study showed USA300
to represent 16% of CA-MRSA and 16% of CA-MSSA iso-
lates [20]. Data has suggested that extra-nare colonization
might be associated with different rates of active infec-
tions; however, there is limited clinical data to support
this assumption [27]. In our study, PVL was present in
only 2 (25%) MRSA isolates and 2 (2%) MSSA isolates.
This is in contrast to previous military colonizing stud-
ies showing nearly 50-67% of MRSA isolates having
PVL [10,12]. Although the accessory gene regulator
(Agr) was present in both study sites, the only statis-
tical difference was Agr III’s presence in MSSA isolates
from personnel in Afghanistan [28].
Despite the use of doxycycline antimalarial prophylaxis
in the deployed population, there was no difference in
doxycycline resistance between the US and Afghanistan
personnel (for both MRSA and MSSA isolates). How-
ever, there was substantially more tetracycline resistance,
especially in association with tetK resistance genes, in
the isolates from Afghanistan personnel. The use of
doxycycline did not appear to induce its own resistance
(even in the presence of tetK resistance genes) as was
shown in a prior study [21]. Our findings are also con-
sistent with a national US survey of discordance between
doxycycline susceptibility and tetracycline resistance
[29]. Of 823 USA300 isolates, 72 (9%) were tetracycline
resistant, and 69 of those were doxycycline susceptible
[29]. In contrast, a prior French military study of personnel
deployed to Cote d’Ivoire (and on doxycycline malaria
chemoprophylaxis) described 2 outbreaks with PVL+,
doxycycline-resistant MRSA infections [30]. Our findings
are also supported by studies of tetracycline therapy for
acne showing no increased rates of tetracycline resistance
in MRSA or MSSA isolates, with possible decreased
colonization rates [31].
The use of antimicrobial agents active against MRSA
and MSSA could have a major impact on the care of cas-
ualties on the battlefield or those injured during natural
disasters or humanitarian relief operations. Due to the
high rate of infections associated with combat-related in-
juries, a standard practice is to initiate antimicrobial ther-
apy at the time of injury [32-34]. Oral moxifloxacin is
currently the recommended field antimicrobial for the US
military unless there is an intraabdominal injury, for which
ertapenem is recommended [33]. However, antimicrobial
agents recommended by the International Committee
of the Red Cross and British military are penicillin or
aminopenicillins [33-35]. Once patients arrive to a US
facility with surgical support, cefazolin is the recommended
antimicrobial agent [33]. Studies have shown that
wounds are colonized with MRSA and MSSA at the
time of injury [36]. There is also data which supports
that moxifloxacin does not select its own resistance for
MRSA/MSSA as it occurs with other fluoroquinolones
[37]. However, well controlled studies are needed to de-
termine the role of post-injury antimicrobials and the
most efficacious agents that also limit selection of in-
creasingly resistant pathogens [38].
There are a number of potential limitations associated
with this study. Although the two study populations
were sampled with different swabs and specimens had
different transportation/storage times prior to pathogen
identification, prior studies (unpublished data by our
group) have shown stability of MRSA/MSSA on different
Table 2 Pulsed-field types, antimicrobial resistance, and resistance and virulence genes, of methicillin-resistant S.
aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates from personnel screened in the US and
Afghanistan (Continued)
Agr I 4(100) 1(25) 5(62) 15(32) 11(31) 26(32)
Agr II 0 1(25) 1(12) 15(32) 12(34) 27(33)
Agr III 0 0 0 0r 11(31)r 11(13)
a Includes isolates with unique PFTs that were also unique to an individual study participant.
b Includes isolates that were unique to individual study participants.
Statistically significant differences (p <0.05):
cUSA 300 in MRSA vs. MSSA colonized personnel for the US personnel.
dUSA 300 in MRSA vs. MSSA colonized personnel for the total personnel.
eAmpicillin-sulbactam susceptibility in MRSA vs. MSSA colonized personnel for the total personnel.
fErythromycin susceptibility in MRSA vs. MSSA colonized personnel for the total personnel.
gmsrA gene presence in MRSA vs. MSSA colonized personnel for the US personnel.
hmsrA gene presence in MRSA vs. MSSA colonized personnel for the total personnel.
iLevofloxacin susceptibility in MRSA vs. MSSA colonized personnel for the US personnel.
jLevofloxacin susceptibility in MRSA vs. MSSA colonized personnel for the total personnel.
kMoxifloxacin susceptibility in MRSA vs. MSSA colonized personnel for the US personnel.
lMoxifloxacin susceptibility in MRSA vs. MSSA colonized personnel for the total personnel.
mtetK presence in MSSA colonized personnel for US vs. Afghan personnel.
ntetM presence in MSSA colonized personnel for US vs. Afghan personnel.
oPVL presence in MRSA vs. MSSA colonized personnel for the total personnel.
pACME presence in MRSA vs. MSSA colonized personnel in US personnel.
qACME presence in MRSA vs. MSSA colonized personnel in total personnel.
rAgr III presence in MSSA colonized personnel for US vs. Afghanistan personnel.
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swab types at different temperatures and storage times.
In addition, the similar colonization rates, colonization
sites, and antimicrobial resistance between the MRSA/
MSSA isolates collected in the US and Afghanistan make
this unlikely an issue. The current study also did not use
broth enrichment media, which may have decreased the
diagnostic sensitivity of bacterial culture results. The
current study determined point prevalence of MRSA/
MSSA colonization and does not provide a complete un-
derstanding of the timeline of colonization in these pop-
ulations. It is not clear whether the Afghanistan-based
population data on overall colonization, MRSA/MSSA
differences, or anatomic-site distribution differences
reflect their exposure to the deployed environment or
simply reflect their baseline colonization. Prospective in-
cidence studies of military personnel prior to deploy-
ments and prior to malaria chemoprophylaxis/antibiotic
exposure are needed to enhance understanding of S.
aureus colonization in these populations. It is unclear if
doxycycline use may have decreased MRSA and MSSA
colonization prevalence from a level that would have
been higher if agents without MRSA/MSSA activity (e.g.
mefloquine, primaquine or atovaquone/proguanil) had
been used for malaria chemoprophylaxis. Individual
doxycycline compliance was not systematically assessed
as part of this study which could contribute to an expos-
ure misclassification; however, deployed unit healthcare
providers estimated compliance to be very high, based
on existing oversight practices for ensuring medication
compliance in a combat zone. The study is also relatively
small, limiting its power to detect actual differences in
prevalence and resistance, and perhaps precluding the
generalization of the findings to larger populations. On
the other hand, the MRSA and MSSA colonization rates
in this study are similar to previous studies conducted in
military and civilian populations. Further, performing
large clinical studies in a combat zone remains a signifi-
cant logistical challenge.
Conclusions
In this pilot study, MRSA and MSSA colonization rates
were not substantially different based on deployment
status and exposure to an austere environment where
antimalarial agents with MRSA/MSSA activity are used.
However, the finding of increased extra-nare site S. aureus
(MRSA and MSSA) colonization should warrant further
investigation, as many decolonization practices focus on
nare and skin, but do not include the oropharynx. Pro-
spective cohort studies are needed to determine the role
of pre-injury colonization on the development of subse-
quent infections in deployed service members, and to en-
hance our understanding of the selection of resistant
pathogens and the impact of decolonization and infection
control measures in the deployed setting.
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